Patients with connective tissue diseases are thought to be at a higher risk for a number of cerebrovascular diseases such as intracranial aneurysms, dissections, and acute ischemic strokes. In this report, we aim to understand the prevalence and occurrences of such neurovascular manifestations in four heritable connective tissue disorders: Marfan syndrome, Ehlers-Danlos syndrome, Neurofibromatosis Type 1, and Loeys-Dietz syndrome. We discuss the fact that although there are various case studies reporting neurovascular findings in these connective tissue diseases, there is a general lack of case-control and prospective studies investigating the true prevalence of these findings in these patient populations. Furthermore, the differences observed in the manifestations and histology of such disease pathologies encourages future multi-center registries and studies in better characterizing the pathophysiology, prevalence, and ideal treatment options of neurovascular lesions in patents with connective tissue diseases.
BrunoLTrediciSMangiavacchiM. Cardiac, skeletal, and ocular abnormalities in patients with Marfan’s syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J1984; 51: 220–230.
3.
LoeysBLDietzHCBravermanAC. The revised Ghent nosology for the Marfan syndrome. J Med Genet2010; 47: 476–485.
4.
DietzHCMcIntoshISakaiLY. Four novel FBN1 mutations: Significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics1993; 17: 468–475.
5.
SchlatmannTJBeckerAE. Histologic changes in the normal aging aorta: Implications for dissecting aortic aneurysm. Am J Cardiol1977; 39: 13–20.
6.
SchlatmannTJBeckerAE. Pathogenesis of dissecting aneurysm of aorta. Comparative histopathologic study of significance of medial changes. Am J Cardiol1977; 39: 21–26.
7.
TrotterSEOlsenEG. Marfan’s disease and Erdheim’s cystic medionecrosis. A study of their pathology. Eur Heart J1991; 12: 83–87.
8.
CollinsMJDevVStraussBH. Variation in the histopathological features of patients with ascending aortic aneurysms: A study of 111 surgically excised cases. J Clin Pathol2008; 61: 519–523.
9.
HirstAEGoreI. Editorial: Is cystic medionecrosis the cause of dissecting aortic aneurysm?Circulation1976; 53: 915–916.
10.
BeightonPDe PaepeASteinmannB. Ehlers–Danlos syndromes: Revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am J Med Genet1998; 77: 31–37.
11.
BeightonPdePaepeADanksD. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet1988; 29: 581–594.
12.
CallewaertBMalfaitFLoeysB. Ehlers–Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol2008; 22: 165–189.
13.
De PaepeAMalfaitF. The Ehlers–Danlos syndrome, a disorder with many faces. Clin Genet2012; 82: 1–11.
14.
EderJLacconeFRohrbachM. A new COL3A1 mutation in Ehlers–Danlos syndrome type IV. Exp Dermatol2013; 22: 231–234.
15.
PierardGEPierard-FranchimontCLapièreCM. Histopathological aid at the diagnosis of the Ehlers–Danlos syndrome, gravis and mitis types. Int J Dermatol1983; 22: 300–304.
16.
LammertMFriedmanJMKluweL. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol2005; 141: 71–74.
17.
EvansDGHowardEGiblinC. Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. Am J Med Genet A2010; 152A: 327–332.
18.
StephensKKayesLRiccardiVM. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet1992; 88: 279–282.
19.
DeBellaKSzudekJFriedmanJM. Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics2000; 105: 608–614.
20.
KorfBR. Diagnostic outcome in children with multiple cafe au lait spots. Pediatrics1992; 90: 924–927.
21.
GutmannDHRasmussenSAWolkensteinP. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology2002; 59: 759–761.
22.
ListernickRFernerREPiersallL. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology2004; 63: 1944–1946.
23.
LewisRAGersonLPAxelsonKA. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology1984; 91: 929–935.
24.
RosserTLVezinaGPackerRJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology2005; 64: 553–555.
25.
HamiltonSJFriedmanJM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet2000; 58: 341–344.
26.
NortonKKXuJGutmannDH. Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis1995; 2: 13–21.
27.
LoeysBLChenJNeptuneER. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet2005; 37: 275–281.
28.
LeMaireSAPannuHTran-FaduluV. Severe aortic and arterial aneurysms associated with a TGFBR2 mutation. Nat Clin Pract Cardiovasc Med2007; 4: 167–171.
29.
MacCarrickGBlackJH3rdBowdinS. Loeys–Dietz syndrome: A primer for diagnosis and management. Genet Med2014; 16: 576–587.
30.
Van LaerLDietzHLoeysB. Loeys–Dietz syndrome. Adv Exp Med Biol2014; 802: 95–105.
31.
LoeysBLSchwarzeUHolmT. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med2006; 355: 788–798.
32.
AalbertsJJvan den BergMPBergmanJE. The many faces of aggressive aortic pathology: Loeys–Dietz syndrome. Neth Heart J2008; 16: 299–304.
33.
MaleszewskiJJMillerDVLuJ. Histopathologic findings in ascending aortas from individuals with Loeys–Dietz syndrome (LDS). Am J Surg Pathol2009; 33: 194–201.
34.
Kim ST, Brinjikji W and Kallmes DF. Prevalence of intracranial aneurysms in patients with connective tissue diseases: A retrospective study. Am J Neuroradiol. Epub ahead of print 18 March 2016. DOI: 10.3174/ajnr.A4718.
35.
ConwayJEHutchinsGMTamargoRJ. Marfan syndrome is not associated with intracranial aneurysms. Stroke1999; 30: 1632–1636.
36.
SchievinkWI. Genetics of intracranial aneurysms. Neurosurgery1997; 40: 651–662. discussion 662–663.
37.
van den BergJSLimburgMHennekamRC. Is Marfan syndrome associated with symptomatic intracranial aneurysms?Stroke1996; 27: 10–12.
38.
Neil-DwyerGBartlettJRNichollsAC. Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study. J Neurosurg1983; 59: 16–20.
39.
DebetteSGermainDP. Neurologic manifestations of inherited disorders of connective tissue. Handb Clin Neurol2014; 119: 565–576.
40.
PepinMSchwarzeUSuperti-FurgaA. Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Engl J Med2000; 342: 673–680.
41.
NorthKNWhitemanDAPepinMG. Cerebrovascular complications in Ehlers–Danlos syndrome type IV. Ann Neurol1995; 38: 960–964.
42.
ConwayJEHutchinsGMTamargoRJ. Lack of evidence for an association between neurofibromatosis type I and intracranial aneurysms: Autopsy study and review of the literature. Stroke2001; 32: 2481–2485.
43.
SchievinkWIRiedingerMMayaMM. Frequency of incidental intracranial aneurysms in neurofibromatosis type 1. Am J Med Genet A2005; 134A: 45–48.
44.
HughesBDPowersCJZomorodiAR. Clipping of a cerebral aneurysm in a patient with Loeys–Dietz syndrome: Case report. Neurosurgery2011; 69: E746–E755. discussion E755.
45.
KellnerCPSussmanESDonaldsonC. Cerebral arterial angioplasty in a patient with Loeys–Dietz syndrome. J Neurointerv Surg2015; 7: e2.
46.
LevittMRMortonRPMaiJC. Endovascular treatment of intracranial aneurysms in Loeys–Dietz syndrome. J Neurointerv Surg2012; 4: e37.
RahmeRJAdelJGBendokBR. Association of intracranial aneurysm and Loeys–Dietz syndrome: Case illustration, management, and literature review. Neurosurgery2011; 69: E488–E492. discussion E492–E493.
49.
RodriguesVJElsayedSLoeysBL. Neuroradiologic manifestations of Loeys–Dietz syndrome type 1. AJNR Am J Neuroradiol2009; 30: 1614–1619.
50.
SchievinkWILinkMJPiepgrasDG. Intracranial aneurysm surgery in Ehlers–Danlos syndrome Type IV. Neurosurgery2002; 51: 607–611. discussion 611–613.
51.
ColbyGPLinLMZeilerSR. Curative reconstruction of a cerebral aneurysm by flow diversion with the Pipeline embolisation device in a patient with Loeys–Dietz syndrome. BMJ Case Rep2014; 2014.
52.
LeeVHBrownRDJrMandrekarJN. Incidence and outcome of cervical artery dissection: A population-based study. Neurology2006; 67: 1809–1812.
HarrerJUSasseAKlötzschC. Intimal flap in a common carotid artery in a patient with Marfan’s syndrome. Ultraschall Med2006; 27: 487–488.
56.
SchievinkWIParisiJEPiepgrasDG. Intracranial aneurysms in Marfan’s syndrome: An autopsy study. Neurosurgery1997; 41: 866–870. discussion 871.
57.
MaskiKPSenguptaSSilveraM. Intracranial artery dissection in an adolescent with Marfan syndrome. Pediatr Neurol2011; 45: 39–41.
58.
KuboYOgasawaraKKuroseA. Ruptured cerebral fusiform aneurysm with mucopolysaccharide deposits in the tunica media in a patient with Marfan syndrome. J Neurosurg2009; 110: 518–520.
59.
DohleCBaehringJM. Multiple strokes and bilateral carotid dissections: A fulminant case of newly diagnosed Ehlers–Danlos syndrome type IV. J Neurol Sci2012; 318: 168–170.
60.
MondonKde ToffolBGeorgescoG. Ehlers Danlos type IV syndrome presenting with simultaneous dissection of both internal carotid and both vertebral arteries [article in French]. Rev Neurol (Paris)2004; 160(4 Pt 1): 478–482.
61.
KurataAOkaHOhmomoT. Successful stent placement for cervical artery dissection associated with the Ehlers–Danlos syndrome. Case report and review of the literature. J Neurosurg2003; 99: 1077–1081.
62.
SengokuRSatoHHondaH. Skin collagen abnormalities in a Japanese patient with extracranial internal carotid artery dissection followed by extracranial vertebral artery dissection [article in Japanese]. Rinsho Shinkeigaku2006; 46: 140–143.
63.
EllisRJSalehinMZhouR. Type IV Ehlers–Danlos syndrome presenting as recurrent, bilateral carotid dissections. BMJ Case Rep2012; 2012.
64.
Chassin-Trubert ContrerasAM. Carotid dissection associated with Ehlers–Danlos syndrome. Report of one case [article in Spanish]. Rev Med Chil2013; 141: 392–395.
65.
BrandtTOrberkEWeberR. Pathogenesis of cervical artery dissections: Association with connective tissue abnormalities. Neurology2001; 57: 24–30.
66.
BrandtTHausserIOrberkE. Ultrastructural connective tissue abnormalities in patients with spontaneous cervicocerebral artery dissections. Ann Neurol1998; 44: 281–285.
67.
UlbrichtDDiederichNJHermanns-LêT. Cervical artery dissection: An atypical presentation with Ehlers–Danlos-like collagen pathology?Neurology2004; 63: 1708–1710.
68.
PeyreMOzanneABhangooR. Pseudotumoral presentation of a cervical extracranial vertebral artery aneurysm in neurofibromatosis type 1: Case report. Neurosurgery2007; 61: E658, discussion E658.
69.
HiramatsuHMatsuiSYamashitaS. Ruptured extracranial vertebral artery aneurysm associated with neurofibromatosis type 1. Case report. Neurol Med Chir (Tokyo)2012; 52: 446–449.
70.
SampeiTYugamiHSumiiT. A case of neurofibromatosis type 1 associated with arteriovenous fistula caused by re-bleeding of a vertebral dissecting aneurysm [article in Japanese]. No Shinkei Geka1999; 27: 927–931.
71.
GoshgarianCLugoASalazarR. Proximal paraparesis due to aortic dissection extending into bilateral carotid arteries in a patient with Loeys–Dietz syndrome. J Clin Neurosci2013; 20: 1790–1792.
72.
BrottTGHalperinJLAbbaraS. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. Catheter Cardiovasc Interv2013; 81: E76–E123.
73.
MarkusHSHayterELeviC. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): A randomised trial. Lancet Neurol2015; 14: 361–367.
74.
ZuccoliGGuidettiDNicoliF. Carotid and vertebral artery dissection: Magnetic resonance findings in 15 cases. Radiol Med2002; 104: 466–471.
75.
HamasakiOIkawaFHidakaT. Extracranial internal carotid artery pseudoaneurysm associated with neurofibromatosis type 1 treated with endovascular stenting and coil embolization. Vasc Endovascular Surg2014; 48: 176–179.
76.
LenningtonBRLasterDWMoodyDM. Traumatic pseudoaneurysm of ascending cervical artery in neurofibromatosis: Complication of chiropractic manipulation. AJNR Am J Neuroradiol1980; 1: 269–270.
77.
DetwilerKGoderskyJCGentryL. Pseudoaneurysm of the extracranial vertebral artery. Case report. J Neurosurg1987; 67: 935–939.
78.
FankhauserGTStoneWMFowlRJ. Surgical and medical management of extracranial carotid artery aneurysms. J Vasc Surg2015; 61: 389–393.
79.
El-KoussyMLovbladKOSteinlinM. Perfusion MRI abnormalities in the absence of diffusion changes in a case of moyamoya-like syndrome in neurofibromatosis type 1. Neuroradiology2002; 44: 938–941.
80.
TanRMChngSMSeowWT. ‘Moya’ than meets the eye: Neurofibromatosis type 1 associated with Moyamoya syndrome. Singapore Med J2008; 49: e107–e109.
81.
VargiamiESapountziESamakovitisD. Moyamoya syndrome and neurofibromatosis type 1. Ital J Pediatr2014; 40: 59.
82.
GolombMRSmithJL. Poor wound healing after pial synangiosis in 2 children with moyamoya vasculopathy associated with neurofibromatosis type 1. J Child Neurol2014; 29: NP101–NP104.
83.
AritaHNaritaYOhnoM. Management of glioblastoma in an NF1 patient with moyamoya syndrome: A case report. Childs Nerv Syst2013; 29: 341–345.
UllrichNJZimmermanMSmithE. Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1. J Child Neurol2011; 26: 228–230.
86.
TatliBEkiciBSencerA. Clinical features, prothrombotic risk factors, and long-term follow-up of eight pediatric Moyamoya patients. J Clin Neurol2012; 8: 100–103.
87.
BarrallJLSummersCG. Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis. Surv Ophthalmol1996; 40: 500–504.
88.
InoueTMatsushimaTFujiiK. Akin moyamoya disease in children [article in Japanese]. No Shinkei Geka1993; 21: 59–65.
89.
KwongKLWongYC. Moyamoya disease in a child with neurofibromatosis type-1. J Paediatr Child Health1999; 35: 108–109.
90.
CairnsAGNorthKN. Cerebrovascular dysplasia in neurofibromatosis type 1. J Neurol Neurosurg Psychiatry2008; 79: 1165–1170.
91.
Duat-RodríguezACarceller LechónFLópez PinoMÁ. Neurofibromatosis type 1 associated with moyamoya syndrome in children. Pediatr Neurol2014; 50: 96–98.
92.
ReaDBrandsemaJFArmstrongD. Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics2009; 124: e476–e483.
93.
LinNBairdLKossM. Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: Radiographic and clinical progression. Neurosurg Focus2011; 31: E6.
94.
UlrichPTJanuschekE. Revascularisation surgery and long-term follow-up in juvenile Moyamoya syndrome: A retrospective analysis. Acta Neurochir Suppl2011; 112: 39–43.
95.
HanCYangWZZhangHT. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1. J Clin Neurosci2015; 22: 286–290.
96.
GhoshPSRothnerADEmchTM. Cerebral vasculopathy in children with neurofibromatosis type 1. J Child Neurol2013; 28: 95–101.
97.
KossMScottRMIronsMB. Moyamoya syndrome associated with neurofibromatosis type 1: Perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr2013; 11: 417–425.
98.
HayashiKMorofujiYHorieN. A case of neurofibromatosis type 1 complicated with repeated intracerebral hemorrhage due to quasi-Moyamoya disease. J Stroke Cerebrovasc Dis2015; 24: e109–e113.
99.
YamamotoYKodamaKYokoyamaS. A pleural solitary fibrous tumor, multiple gastrointestinal stromal tumors, Moyamoya disease, and hyperparathyroidism in a patient associated with NF1. Case Rep Surg2015; 2015: 375416.
100.
Siqueira NetoJISilvaGSDe CastroJD. Neurofibromatosis associated with moyamoya arteriopathy and fusiform aneurysm: Case report [article in Portuguese]. Arq Neuropsiquiatr1998; 56: 819–823.
101.
HattoriSKiguchiHIshiiT. Moyamoya disease with concurrent von Recklinghausen’s disease and cerebral arteriovenous malformation. Pathol Res Pract1998; 194: 363–369.
102.
GraciaCMBittencourtPCMazerS. Neurofibromatosis and extensive intracranial arterial occlusive disease (moyamoya disease). Report of a case [article in Portuguese]. Arq Neuropsiquiatr1986; 44: 395–400.
103.
KocFYerdelenDKocZ. Neurofibromatosis type 1 association with moyamoya disease. Int J Neurosci2008; 118: 1157–1163.
104.
HoriguchiSMitsuyaKWatanabeR. Pleomorphic xanthoastrocytoma and moyamoya disease in a patient with neurofibromatosis type 1—case report. Neurol Med Chir (Tokyo)2011; 51: 310–314.
105.
TerryARJordanJTSchwammL. Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: Population-based approach. Stroke2016; 47: 60–65.
106.
MurayamaYUsamiSAbeT. Transvenous Doppler guidewire sonographic monitoring during treatment of a complex vertebral arteriovenous fistula associated with neurofibromatosis type 1. Neuroradiology1999; 41: 328–333.
107.
KamiyamaKEndoSHorieY. Neurofibromatosis associated with intra- and extracranial aneurysms and extracranial vertebral arteriovenous fistula [article in Japanese]. No Shinkei Geka1985; 13: 875–880.
108.
HigaGPacanowskiJPJrJeckDT. Vertebral artery aneurysms and cervical arteriovenous fistulae in patients with neurofibromatosis 1. Vascular2010; 18: 166–177.
109.
HughesDGAlleyneCHJr. Rare giant traumatic cervical arteriovenous fistula in neurofibromatosis type 1 patient. BMJ Case Rep2012; 2012.
110.
KāhārāVLehtoURyyminP. Vertebral epidural arteriovenous fistula and radicular pain in neurofibromatosis type I. Acta Neurochir (Wien)2002; 144: 493–496.
111.
SaitoATakahashiTEzuraM. Intercostal arteriovenous fistula associated with neurofibromatosis manifesting as congestive myelopathy: Case report. Neurosurgery2007; 61: E656–E657. discussion E657.
112.
KoenigsbergRAAletichVDebrunG. Cervical vertebral arteriovenous fistula balloon embolization in a patient with neurofibromatosis type 1. Surg Neurol1997; 47: 265–273.
113.
AnegawaSHayashiTTorigoeR. Symptomatic arteriovenous fistula in a patient with neurofibromatosis type I [article in Japanese]. No Shinkei Geka1997; 25: 373–378.
114.
WadaKOhtsukaKTerayamaK. Neurofibromatosis with spinal paralysis due to arteriovenous fistula. Arch Orthop Trauma Surg1989; 108: 322–324.
115.
KubotaTNakaiHTanakaT. A case of intracranial arteriovenous fistula in an infant with neurofibromatosis type 1. Childs Nerv Syst2002; 18: 166–170.
116.
TanakaTHasegawaYKankiT. Combination of intravascular surgery and surgical operation for occipital subcutaneous arteriovenous fistula in a patient with neurofibromatosis type I [article in Japanese]. No Shinkei Geka2002; 30: 309–313.
117.
JohnsonCERussellEJHuckmanMS. Resolution of spinal epidural vascular pseudotumor following balloon occlusion of a postoperative vertebral arteriovenous fistula. Neuroradiology1990; 31: 529–532.
118.
SchievinkWIPiepgrasDG. Cervical vertebral artery aneurysms and arteriovenous fistulae in neurofibromatosis type 1: Case reports. Neurosurgery1991; 29: 760–765.
119.
RothTCMannessWKHersheyBL. Complex vertebral arteriovenous fistula and ruptured aneurysm in neurofibromatosis: A therapeutically challenging case. Skull Base Surg2000; 10: 35–41.
120.
SiddharthaWChavhanGBShrivastavaM. Endovascular treatment for bilateral vertebral arteriovenous fistulas in neurofibromatosis 1. Australas Radiol2003; 47: 457–461.
121.
HoriYGotoKOgataN. Diagnosis and endovascular treatment of vertebral arteriovenous fistulas in neurofibromatosis type 1. Interv Neuroradiol2000; 6: 239–250.
122.
MaheshwariSKaleHADesaiSB. Magnetic resonance imaging findings in an unusual case of atlanto axial dislocation and vertebral artery-vein fistulas in a patient of neurofibromatosis-1. Australas Radiol2002; 46: 316–318.
GuzelATatliMErU. Surgical treatment of cervical arteriovenous fistula in a patient with neurofibromatosis type 1. A case report. Neuroradiol J2007; 20: 566–569.
125.
HasegawaHBitohSKatohA. Bilateral vertebral arteriovenous fistulas and atlantoaxial dislocation associated with neurofibromatosis—case report. Neurol Med Chir (Tokyo)1989; 29: 55–59.
126.
PaoliniSColonneseCGalassoV. Extradural arteriovenous fistulas involving the vertebral artery in neurofibromatosis Type 1. J Neurosurg Spine2008; 8: 181–185.
127.
BenndorfGAssmannUBenderA. Vertebral arteriovenous fistula associated with neurofibromatosis type I misdiagnosed as a giant aneurysm. Interv Neuroradiol2000; 6: 67–74.
128.
PatroSNGuptaAKArvindaHR. Combined transarterial and percutaneous coiling of a spontaneous vertebrovertebral fistula associated with neurofibromatosis type 1. Case report. J Neurosurg2009; 111: 37–40.
129.
TakegamiTImaiKUmezawaK. Endovascular trapping using a tandem balloon technique for a spontaneous vertebrovertebral fistula associated with neurofibromatosis type 1 [article in Japanese]. No Shinkei Geka2012; 40: 705–709.
130.
DesalHAToulgoatFRaoulS. Ehlers–Danlos syndrome type IV and recurrent carotid-cavernous fistula: Review of the literature, endovascular approach, technique and difficulties. Neuroradiology2005; 47: 300–304.
131.
NakagawaIParkHSWadaT. A novel approach to the treatment of a direct carotid-cavernous fistula in a patient with Ehlers–Danlos syndrome type IV. BMJ Case Rep2014; 2014.
132.
LinfanteILinEKnottE. Endovascular repair of direct carotid-cavernous fistula in Ehlers–Danlos type IV. BMJ Case Rep2014; 2014.
133.
NakagawaIParkHSWadaT. A novel approach to the treatment of a direct carotid-cavernous fistula in a patient with Ehlers–Danlos syndrome type IV. J Neurointerv Surg2016; 8: e2.
134.
KimJGChoWSKangHS. Spontaneous carotid-cavernous fistula in the type IV Ehlers–Danlos syndrome. J Korean Neurosurg Soc2014; 55: 92–95.
135.
KhanAChaudharyNPandeyAS. Direct puncture of the highest cervical segment of the internal carotid artery for treatment of an iatrogenic carotid cavernous fistula in a patient with Ehlers–Danlos syndrome. J Neurointerv Surg2012; 4: e29.
136.
WangQChenG. Endovascular treatment of bilateral multiple carotid-cavernous fistulas in a patient with Ehlers–Danlos syndrome. J Neurol Surg A Cent Eur Neurosurg2013; 74(Suppl 1): e41–e44.
137.
ForlodouPde Kersaint-GillyAPizzanelliJ. Ehlers–Danlos syndrome with a spontaneous caroticocavernous fistula occluded by detachable balloon: Case report and review of literature. Neuroradiology1996; 38: 595–597.
138.
KannerAAMaimonSRappaportZH. Treatment of spontaneous carotid-cavernous fistula in Ehlers–Danlos syndrome by transvenous occlusion with Guglielmi detachable coils. Case report and review of the literature. J Neurosurg2000; 93: 689–692.
139.
HorowitzJ. Unusual presentation of a carotid-cavernous fistula in Ehlers–Danlos type IV [article in Hebrew]. Harefuah2013; 152: 106–108, 122.
140.
LachBNairSGRussellNA. Spontaneous carotid-cavernous fistula and multiple arterial dissections in type IV Ehlers–Danlos syndrome. Case report. J Neurosurg1987; 66: 462–467.
141.
KashiwagiSTsuchidaEGotoK. Balloon occlusion of a spontaneous carotid-cavernous fistula in Ehlers–Danlos syndrome type IV. Surg Neurol1993; 39: 187–190.
142.
FarleyMKClarkRDFallorMK. Spontaneous carotid-cavernous fistula and the Ehlers–Danlos syndromes. Ophthalmology1983; 90: 1337–1342.
143.
HollandsJKSantariusTKirkpatrickPJ. Treatment of a direct carotid-cavernous fistula in a patient with type IV Ehlers–Danlos syndrome: A novel approach. Neuroradiology2006; 48: 491–494.
144.
UsinskieneJMazighiMBisdorffA. Fatal peritoneal bleeding following embolization of a carotid-cavernous fistula in Ehlers–Danlos syndrome type IV. Cardiovasc Intervent Radiol2006; 29: 1104–1106.
145.
ChumanHTrobeJDPettyEM. Spontaneous direct carotid-cavernous fistula in Ehlers–Danlos syndrome type IV: Two case reports and a review of the literature. J Neuroophthalmol2002; 22: 75–81.
BashirQThorntonJAlpS. Carotid-cavernous fistula associated with Ehlers–Danlos syndrome type IV. A case report and review of literature. Interv Neuroradiol1999; 5: 313–320.
148.
Van OvermeireODe KeukeleireKvan LangenhoveP. Carotid-cavernous fistula in Ehlers–Danlos syndrome by pure transvenous approach. Interv Neuroradiol2006; 12: 45–51.
149.
HalbachVVHigashidaRTDowdCF. Treatment of carotid-cavernous fistulas associated with Ehlers–Danlos syndrome. Neurosurgery1990; 26: 1021–1027.
150.
KojimaASagaITomioR. Aggressive change of a carotid-cavernous fistula in a patient with Ehlers–Danlos syndrome type IV. Interv Neuroradiol2015; 21: 341–345.
151.
TanakaTHayakawaMSadatoA. Transvenous embolization for carotid-cavernous fistula in a patient with vascular type of Ehlers–Danlos syndrome—direct superior ophthalmic vein approach: Case report. Neurol Med Chir (Tokyo)2014; 54: 155–160.
152.
MitsuhashiTMiyajimaMSaitohR. Spontaneous carotid-cavernous fistula in a patient with Ehlers–Danlos syndrome type IV—case report. Neurol Med Chir (Tokyo)2004; 44: 548–553.
